ProShares Ultra Nasdaq Biotechnology (BIB)

Add to Watchlists
Create an Alert
53.20 +1.92  +3.74% NASDAQ Aug 22, 16:59 Delayed 2m USD
View Full Chart
BIB Price Chart

BIB Key Stats

BIB Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -12.34% -- --
3M 8.87% -- --
6M 6.39% -- --
1Y 4.27% -- --
3Y 1.72% -- --
5Y 30.30% -- --
10Y -- -- --
As of Aug. 21, 2017. Returns for periods of 1 year and above are annualized.

BIB Asset Allocation

Type % Net % Long % Short
Cash -97.12% 23.90% 121.0%
Stock 76.10% 76.10% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 121.0% 124.0% 2.95%
As of July 31, 2017
View More Holdings

BIB Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Bank Of America Na 37.79% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 26.12% -- --
-- Ishares Biotech (Ibb) Swap Bank Of America Na 25.82% -- --
-- Nasdaq Biotechnology Index Swap Credit Suisse International 15.05% -- --
CELG Celgene Corp 6.47% 130.27 +2.23%
GILD Gilead Sciences Inc 6.41% 73.37 +1.06%
BIIB Biogen Inc 6.39% 286.71 +1.26%
AMGN Amgen Inc 6.14% 170.05 +1.12%
-- Nasdaq Biotechnology Index Swap Ubs Ag 5.86% -- --
REGN Regeneron Pharmaceuticals Inc 5.62% 478.21 +1.80%
As of July 31, 2017
Advertisement

BIB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
200.0%

BIB Manager Info

Name Tenure
Devin Sullivan 0.75 yrs
Michael Neches 3.75 yrs

BIB Net Fund Flows

1M 45.99M
3M 14.73M
6M -57.68M
YTD -92.89M
1Y -91.71M
3Y 102.45M
5Y 292.36M
10Y --
As of July 31, 2017

BIB Risk Info

Beta (5Y) 2.549
Max Drawdown (All) 67.24%
Historical Sharpe (10Y) --
Historical Sortino (All) 1.403
30-Day Rolling Volatility 31.27%
Daily Value at Risk (VaR) 1% (All) 8.21%
Monthly Value at Risk (VaR) 1% (All) 32.74%

BIB Comparables

Edit

BIB Attributes

Key Dates
Inception Date 4/6/2010
Last Annual Report Date 5/31/2017
Last Prospectus Date 10/19/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

BIB Excel Add-In Codes

  • Name: =YCI("BIB","name")
  • Broad Asset Class: =YCI("BIB", "broad_asset_class")
  • Broad Category: =YCI("BIB", "broad_category_group")
  • Prospectus Objective: =YCI("BIB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.